Managing chronic pain with encapsulated cell implants releasing catecholamines and endogenous opiods

Frontiers in Bioscience

Volumn 10, Issue 1, 2005, Pages 367-378

  Winn, Shelley R ^a,c   Emerich, Dwaine F ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LCT BioPharma Inc ^*  (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Analgesia; Cellular encapsulation; Chronic pain; Immunoisolation; Met enkephalin; Norepinephrine; Review

Indexed keywords

CATECHOLAMINE; METENKEPHALIN; NORADRENALIN; OPIATE;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; CELL ENCAPSULATION; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CHROMAFFIN CELL; CHRONIC PAIN; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; QUANTITATIVE ANALYSIS; REVIEW; SAFETY;

ANIMALIA; BOVINAE; OVIS ARIES;

EID: 17444427705     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1534     Document Type: Review

References (68)

1. Sladek, J. R. and D. M. Gash: Neural Transplants, Eds. J. R. Sladek and D. M. Gash, Plenum, New York (1984)
2. Björklund, A and U. Stenevi: Neural Grafting in the Mammalian CNS, Eds. Björklund A and U. Stenevi, Elsevier Science, Amsterdam, 709 (1995)
3. Sortwell, C. E., F. Petty, G. Kramer and J. Sagen: In vivo release of catecholamines from xenogeneic chromaffin cell grafts with antidepressive activities. Exp Neurol 130, 1-8 (1994)
4. Czech, K. and J. Sagen: Update on cellular transplantation into the CNS as a novel therapy for chronic pain. Prog Neurobiol 46, 507-522 (1995)
5. Barami, K. and F. G. Diaz: Cellular transplantation and spinal cord injury. Neurosurg 47, 691-7000 (2000)
6. Livett, B., D. M. Dean, L. G. Whelan, S. Udenfield and J. Rossier: Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells. Science 225, 734-737 (1981)
7. Yang, H. Y. T., T. Hexum and E. Costa: Opiod peptide in the adrenal gland. Life Sci 27, 1119-1125 (1980)
8. Wilson, S., K. Chang and O. H. Viveros: Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture. J Neurosci s 2, 1150-1156 (1982)
9. Carmichael, S. and H. Winkler: The adrenal chromaffin cell. Sci Amer 253, 40-49 (1985)
10. Hua, X. Y., J. H. Boublik, M. A. Spicer, J. E. Rivier, M. R. Brown and T. L. Yaksh: The antinociceptive effects of spinally administrated neuropeptide Y in the rat: systemic studies on structure-activity relationship. J Pharmacol Exp Ther 258, 243-248 (1991)
11. Coupland, R. E: The natural history of the chromaffin cell: Twenty-five years on the beginning. Arch Histol Cytol 52, S331-341 (1989)
12. Yaksh, T. L. and S. V. R. Reddy: Studies in the primate on the analgesic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology 54, 451-467 (1981)
13. Sagen, J., G. D. Pappas and M. J. Perlow: Adrenal medullary transplants in the rat spinal cord reduce pain sensitivity. Brain Res 384, 189-194 (1986)
14. Sagen, J., G. D. Pappas and H. Pollard: Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord. Proc Natl Acad Sci USA 83, 7552 (1986)
15. Sagen, J., G. D. Pappas and M. J. Perlow: Alterations in nociception following adrenal medullary transplants into the rat periaqueductal gray. Exp. Brain Res 67, 373-379 (1987)
16. Sagen, J., H. Wang and G. D. Pappas: Adrenal medullary tissue implants in rat spinal cord reduce nociception in a chronic pain model. Pain 42, 69-79 (1990)
17. Sagen, J., J. Kemmler and H. Wang: Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity. J Neurochem 56, 623-627 (1991)
18. Sagen, J., G. D. Pappas and A. P. Winnie: Alleviation of pain in cancer patients by adrenal medullary transplants in the spinal subarachnoid space. Cell Transplant. 2, 259-266 (1993)
19. Winnie, A., G. D. Pappas, T. K. Gupta, H. Wang, J. Ortega and J. Sagen: Subarachnoid adrenal medullary transplants for terminal cancer pain. Anesthesiology 79, 644-653 (1993)
20. Lazorthes, Y., J. C. Bès, J. Sagen, M. Tafani, J. Tkaczuk, B. Sallerin, I. Nahri, J. C. Verdié, E. Ohayon, C. Caratero and G. D. Pappas: Transplantation of human chromaffin cells for intractable cancer pain control. Acta Neurochir 64S, 97-100 (1995)
21. Lazorthes, Y., G. D. Pappas, J. C. Bès, J. Sagen, M. Tafani, A. P. Winnie, and J. Tkaczuk: Human chromaffin cell therapy for cancer pain: clinical, biochemical and anatomical data with long-term follow-up. Acta Neurochir 138, 606-610 (1996)
22. Ehde, D. M., M. P. Jensen, J. M. Engel, J. A. Turner, A. J. Hoffman and D. D. Cardenas: Chronic pain secondary to disability: a review. Clin. J Pain 19, 3-17 (2003)
23. Cancer pain relief and palliative care. Geneva, Switzerland: World Health Organization, technical report series, 804, (1990)
24. Ballantyne, J. C: Chronic pain following treatment for cancer: the role of opiods. The Oncologist 8, 567-575, (2003)
25. Hama, A. T. and J. Sagen: Reduced pain-related behavior by adrenal medullary transplants in rats with experimental pain neuropathy. Pain 52, 223-231 (1993)
26. Hama, A. T. and J. Sagen: Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space. Brain Res 651, 183-193 (1994)
27. Sagen, J., H. Wang, A. T. Hama and G. D. Pappas: Adrenal chromaffin cells: preparation and use in pain models. In: C. Ricordi, Editor, Methods in Cell Transplantation, Landes, Austin (1995)
28. Siegan, J. B. and J. Sagen: Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space. Pain 70, 279-285 (1997)
29. Decosterd, I., E. Buchser, N. Gilliard, J. Saydoff, A. D. Zurn and P. Aebischer: Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain. Pain 76, 159-166 (1998)
30. Aebischer, P., E. Buchser, J. M. Joseph, J. Favre, N. de Tribolet, M. Lysaught, S. Rudnick, and M. Goddard: Transplantation in humans of encapsulated xenogeneic cells without immunosuppression: A preliminary report. Transplantation 58, 1-3, (1994)
31. Burgess, F. W., M. Goddard, D. Savarese, and H. Wilkinson: Subarachnoid bovine adrenal chromaffin cell implants for cancer pain management. Anesthesiology 85, 796 (1996)
32. Buchser, E., M. Goddard, B. Heyd, J .M. Joseph, J. Favre, N. de Tribolet, M. Lysaught, and P. Aebischer: Immunoisolated xenogeneic chromaffin cell therapy for chronic pain: initial clinical experience. Anesthesiology 85, 1005-1012 (1996)
33. Sagen, J., H. Wang, P. Tresco and P. Aebischer: Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances. J Neurosci 13, 2415-2423 (1993)
34. Aebischer, P., S. R. Winn and P. M. Galletti: Transplantation of neural tissue in polymer capsules. Brain Res 448, 364-368 (1988)
35. Christenson, L., K. E. Dionne and M. J. Lysaght: Biomedical applications of immobilized cells. In: Fundamentals of Animal Cell Encapsulation and Immobilization. Eds: M.F.A. Goosen. CRC Press, Inc., Boca Raton, FL, 7-41 (1993)
36. Winn, S. R. and P. A. Tresco: Hydrogel applications for encapsulated cellular transplants. In: Methods in Neuroscience: Providing Pharmacological Access to the Brain. Eds: T. R. Flanagan, D. F. Emerich and S. R. Winn. Academic Press, San Diego, CA, Vol. 21, 387-402 (1994)
37. Aebischer, P., P. A. Tresco, J. Sagen and S. R. Winn: Transplantation of microencapsulated bovine chromaffin cells reduces lesioned-induced rotational asymmetry in rats. Brain Res 560, 43-49 (1991)
38. Crooks, C. A., J. A. Douglas, R. L. Broughton and M. V. Sefton: Microencapsulation of mammalian cells in a HEMA-MMA copolymer: effects on capsule morphology and permeability. J Biomed Mater Res 24, 1241-1262 (1990)
39. Gentile, F. T., E. J. Doherty, D. H. Rein, M. S. Shoichet and S. R. Winn: Polymer science for cell encapsulation. J Reactive Polymers 25, 207-227 (1995)
40. Shoichet, M. S. and S. R. Winn: Cell delivery to the central nervous system. Adv Drug Deliv Rev 42, 81-102, (2000)
41. Emerich, D. F. and S. R. Winn: Immunoisolation cell therapy for CNS Diseases. Crit Rev Ther Drug Carrier Syst 18, 265-298, (2001)
42. Joseph, J. M., M. B. Goddard, J. Mills, V. Padrun, A. Zurn, B. Zielinski, J. Favre, J. P. Gardez, F. Mosimann, J. Sagen, L. Christenson and P. Aebischer: Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: A preclinical study for the treatment of cancer pain. Cell Transpl 5, 355-364 (1994)
43. Lindner, M. D., M. A. Plone, B. Frydel, F. A. Kaplan, P. M. Krueger, W. J. Bell, T. J. Blaney, S. R. Winn, S. S. Sherman, E. J. Doherty and D. F. Emerich: Intraventricular encapsulated calf adrenal chromaffin cells: viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats. Restor Neurol Neurosci 11, 21-35 (1997)
44. Gentile, F. T., E. J. Doherty, D. H. Rein, M. S. Shoichet and S. R. Winn: Polymer science for macroencapsulation of cells for central nervous system transplantation. Reactive Polymers 25, 207-227 (1995)
45. Gaya, S. B., A. J. Rees, R. I. Lechler, G. Williams and P. D. Mason: Malignant disease in patients with long-term renal transplants. Transplantation 59, 1705-1709 (1995)
46. London, N. J., S. M. Farmery, E. J. Will, A. M. Davison and J. P. Lodge: Risk of neoplasia in renal tranplant patients. Lancet 346, 403-406 (1995)
47. Balistreri, F., J. C. Bucuvalas and F. C. Ryckman: The effect of immunosuppression on growth and development. Liver Transpl Surg 1, 64-73 (1995)
48. Gremlich, S., R. Roduit and B. Thorens: Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids. J Biol Chem 272, 3216-3222 (1997)
49. Hahn, H. J., F. Laube, S. Kloting, K. D. Kohnert and R. Warzock: Toxic effects of cyclosporin on the endocrine pancreas of Wistar rats. Transplantation 41, 44-47 (1986)
50. Aebischer, P., P. A. Tresco, S. R. Winn, L. A. Greene and C. B. Jaeger: Long-team cross-species brain transplantation of a polymer encapsulated dopamine-secreting cell line. Exp Neurol 111, 269-275 (1991)
51. Tresco, P. A., S. R. Winn, C. B. Jaeger, L. A. Greene and P. Aebischer: Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesioned-induced rotational behavior. Cell Transpl 1, 255-264 (1992)
52. Sagen, J., A. T. Hama, S. R. Winn, P. A. Tresco and P. Aebischer: Pain reduction by spinal implantation of xenogeneic chromaffin cells immunologically-isolated in polymer capsules. Soc Neursci Abstr 19, 234 (1993)
53. Winn, S. R., M. D. Lindner, G. Haggett, J. M. Francis and D. F. Emerich: Polymer-encapsulated genetically-modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences. Exp Neurol 140, 126-138 (1996)
54. Subramanian, T., D. F. Emerich, R. A. E. Bakay, J. M. Hoffman, M. M. Goodman, T. M. Shoup, G. W. Miller, A. I. Levey, G. W. Hubert, S. Batchelor, S. R. Winn, J. A. Saydoff and R. L. Watts: Polymer-encapsulated PC12 cells demonstrate high affinity uptake of dopamine in vitro and 18F-dopa uptake and metabolism after intracerebral implantation in nonhuman primate. Cell Transpl 6, 469-477 (1997)
55. Aebischer, P., M. Schleup, N. Deglon, J-M. Joseph, L. Hirt, B. Heyd, M. Goddard, J. P. Hammang, A. D. Zurn, A. C. Kato, F. Regli and E. E. Baetge: Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Med 2, 696-699 (1996)
56. Date, T. Shingo, T. Ohmoto and D. F. Emerich: Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymerencapsulated human NGF-secreting cells. Exp Neurol 147, 10-17 (1997)
57. Lazorthes, Y., J. Sagen, B. Sallerin, J. Tkaczuk, H Duplan, J. C. Sol, M. Tafani, and J. C. Bès: Human chromaffin cell graft into the CSF for cancer pain management: a prospective phase II clinical study. Pain 87, 19-32 (2000)
58. Wang, H. and J. Sagen: Absence of appreciable tolerance and morphine cross-tolerance in rats with adrenal medullary transplants in the spinal cord. Neuropharmacology 33, 681-692 (1994)
59. Lindner, M. D., J. M. Francis, M. A. Plone, P. E. McDermott, B. R. Frydel, D. F. Emerich and J. A. Saydoff: The analgesic potential of intraventricular polymer-encapsulated adrenal chromaffin cells in a rodent model of chronic neuropathic pain. Exp Clin Psychopharmacol 8, 524-538 (2000)
60. Lindner, M. D., J. M. Francis and J. A. Saydoff: Intrathecal polymer-encapsulated bovine chromaffin cells fail to produce analgesic effects in the hotplate and formalin tests. Exp Neurol 165, 370-383 (2000)
61. Lindner, M. D., J. M. Francis, P. E. McDermott, W. J. Bell, T. J. Blaney, S. S. Sherman and J. A. Saydoff: Numerous adrenal chromaffin cell preparations fail to produce analgesic effects in the formalin test or in tests of acute pain even with nicotine stimulation. Pain 88, 177-188 (2000)
62. Eaton, M. J., B. R. Frydel, T. L. Lopez, X. T. Nie, J. Huang, J. McKillop and J. Sagen: Generation and initial characterization of conditionally immortalized chromaffin cells J Cell Biochem 79, 38-57 (2000)
63. De la Calle, J. L., M. A. Mena, J. R. Gonzalez-Escalada and C. L. Paino: Intrathecal transplantation of neuroblastoma cells decreases heat hyperalgesia and cold allodynia in a rat model of neuropathic pain. Brain Res Bull 59, 205-11 (2002)
64. Eaton, M. J., J. A. Plunkett, M. A. Martinez, T. Lopez, S. Karmally, P. Cejas and S. R. Whittemore:Transplants of neuronal cells bioengineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transpl 8, 87-101 (1999)
65. Stubley, L. A., M. A. Martinez, S. Karmally, T. Lopez, P. Cejas and M. J. Eaton: Only early intervention with gamma-aminobutyric acid cell therapy is able to reverse neuropathic pain after partial nerve injury. J Neurotrauma 18, 471-7 (2001)
66. Eaton, M. J., S. Karmally, M. A. Martinez, J. A. Plunkett, T. Lopez and P. J. Cejas: Lumbar transplant of neurons genetically modified to secrete galanin reverse pain-like behaviors after partial sciatic nerve injury. J Peripher Nerv Syst 4, 245-57 (2000)
67. Eaton, M. J., D. I. Santiago, H. A. Dancausse and S. R. Whittemore: Lumbar transplants of immortalized serotonergic neurons alleviate chronic neuropathic pain. Pain 72, 59-69 (1997)
68. Cejas, P. J., M. Martinez, S. Karmally, M. McKillop, J. McKillop, J. A. Plunkett, M. Oudega and M. J. Eaton: Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction. Pain 86, 195-210 (2000)